Journal of General Internal Medicine

, Volume 9, Issue 6, pp 336–338 | Cite as

Routine prolactin measurement is not necessary in the initial evaluation of male impotence

  • Basil E. Akpunonu
  • Anand B. Mutgi
  • Douglas J. Federman
  • Jill York
  • Lee S. Woldenberg
Brief Reports


The authors determined the prevalence of hyperprolactinemia in impotent men in a community setting and assessed the cost of case detection with routine estimation of serum prolactin. They recruited 299 consecutive patients with impotence and determined the hormonal levels (prolactin, luteinizing hormone, follicle-stimulating hormone, and testosterone). Pituitary gland imaging was done when the prolactin level was elevated. Simultaneous prolactin and testosterone levels were available for 212 patients. Three patients (1.4% ) had elevated prolactin levels but none had pituitary tumor. Two of these had low testosterone levels. Overall, 51 patients (24.1%) had low testosterone levels. Cost of selective prolactin estimation in patients with low testosterone levels resulted in a net saving of $2,574 per case detected. The authors conclude that the prevalence of hyperprolactinemia in impotence is low. Routine measurement of prolactin levels in impotence is not indicated. Selective determination in patients with low testosterone reduces the cost of diagnostic evaluation.

Key words

prolactin men impotence testosterone screening tests 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Krane R. Sexual function and dysfunction. In: Campbell’s Urology, 5th edition. Philadelphia: W. B. Saunders, 1986;717.Google Scholar
  2. 2.
    Whitehead ED, Klyde BJ, Zussman S, Salkin P. Diagnostic evaluation of impotence. Postgrad Med. 1990;8:123–36.Google Scholar
  3. 3.
    Krane RJ, Goldstein I, Saenz de Tejada I. Impotence. N Engl J Med. 1989;321:1648–59.PubMedCrossRefGoogle Scholar
  4. 4.
    Korenman SG. Sexual dysfunction. In: Williams’ Textbook of Endocrinology, 8th edition. Philadelphia: W. B. Saunders, 1992;1039.Google Scholar
  5. 5.
    Carter JN, Tyson JE, Tolis G, Van Vliet S, Faiman C, Friesen HG. Prolactin secreting tumors and hypogonadism in 22 men. N Engl J Med. 1978;299:847–52.PubMedCrossRefGoogle Scholar
  6. 6.
    Franks S, Jacobs HS, Martin N, Nabarro JDN. Hyperprolactinaemia and impotence. Clin Endocrinol. 1978;8:277–87.Google Scholar
  7. 7.
    Miller JB, Howards SS, McLeod RM. Serum prolactin in organic and psychogenic impotence. J Urol. 1980;123:862–4.PubMedGoogle Scholar
  8. 8.
    Modebo O. Serum prolactin concentration in impotence in African males. Andrologia. 1989;21(1):42–7.CrossRefGoogle Scholar
  9. 9.
    Hargrave TB, Kyle KF, Kelley AM, England P. Prolactin and gonadotrophins in 208 men presenting with infertility. Br J Urol. 1977;49:747–50.CrossRefGoogle Scholar
  10. 10.
    Buvat J, Lemaire A, Buvat-Herbaut M, Fourlinnie JC, Racadot A, Fossati P. Hyperprolactinemia and sexual function in men. Horm Res. 1985;22:196–203.PubMedGoogle Scholar
  11. 11.
    Leonard MP, Nickel CJ, Morales A. Hyperprolactinemia and impotence. Why, when, and how to investigate. J Urol. 1989;142:992–4.PubMedGoogle Scholar
  12. 12.
    Maatman TJ, Montague DK. Routine endocrine screening in impotence. Urology. 1986;27:499–502.PubMedCrossRefGoogle Scholar
  13. 13.
    Nickel JC, Morales A, Condra M, Fenemore J, Surridge DH. Endocrine dysfunction in impotence. Incidence significance and cost effective screening. J Urol. 1984;132:40–3.PubMedGoogle Scholar
  14. 14.
    Hursch CJ, Karacan I, Williams RL. Some characteristics of penile tumescence in early middle-aged males. Compr Psychiatry. 1972;13:539–48.PubMedCrossRefGoogle Scholar
  15. 15.
    Wein AJ, Fishkin R, Carpiniello VL, Malloy TR. Expansion without significant rigidity during nocturnal penile tumescence testing. A potential source of misinterpretation. J Urol. 1981;126:343–4.PubMedGoogle Scholar
  16. 16.
    Farlow WM. Prevalence of impotence in the United States. Med Aspect Hum Sexuality. 1985;19:13–6.Google Scholar
  17. 17.
    Katz E, Adashi EY. Hyperprolactinemic disorders. Clin Obstet Gynecol. 1990;33:622–39.PubMedCrossRefGoogle Scholar
  18. 18.
    Foster RS, Mulcahy JJ, Callaghan JT, Crabtree R, Brashear D. Role of serum prolactin determination in evaluation of impotent patient. Urology. 1990;36:499–501.PubMedCrossRefGoogle Scholar
  19. 19.
    Johnson AR III, Jarow JP. Is routine endocrine testing of impotent men necessary? J Urol. 1992;147:1542–4.PubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine 1994

Authors and Affiliations

  • Basil E. Akpunonu
    • 1
  • Anand B. Mutgi
  • Douglas J. Federman
  • Jill York
  • Lee S. Woldenberg
  1. 1.Department of MedicineMedical College of OhioToledo

Personalised recommendations